General MedicationsINTRAVENOUSStandard
PEDMARK
SODIUM THIOSULFATE
Standard Dose
12.5GM/100ML (125MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview PEDMARK is listed in Drugs@FDA under application 212937 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient SODIUM THIOSULFATE Form and strength SOLUTION;INTRAVENOUS - 12.5GM/100ML (125MG/ML) Sponsor FENNEC PHARMS INC Submission history Latest submission status date: 2022-09-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview PEDMARK is listed in Drugs@FDA under application 212937 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient SODIUM THIOSULFATE Form and strength SOLUTION;INTRAVENOUS - 12.5GM/100ML (125MG/ML) Sponsor FENNEC PHARMS INC Submission history Latest submission status date: 2022-09-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.